DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.28 Billion USD | 21.55% |
| 2022 | 1.88 Billion USD | 12.06% |
| 2021 | 1.68 Billion USD | 31.28% |
| 2020 | 1.28 Billion USD | 37.42% |
| 2019 | 931.5 Million USD | 40.31% |
| 2018 | 663.9 Million USD | 34.91% |
| 2017 | 492.1 Million USD | 30.05% |
| 2016 | 378.4 Million USD | 35.92% |
| 2015 | 278.4 Million USD | 57.91% |
| 2014 | 176.3 Million USD | 76.12% |
| 2013 | 100.1 Million USD | 114.81% |
| 2012 | 46.6 Million USD | 30.01% |
| 2011 | 35.84 Million USD | 94.35% |
| 2010 | 18.44 Million USD | 403.77% |
| 2009 | 3.66 Million USD | 166.21% |
| 2008 | -5.52 Million USD | 31.82% |
| 2007 | -8.1 Million USD | 7.74% |
| 2006 | -8.78 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 626.7 Million USD | 11.53% |
| 2024 Q3 | 593.8 Million USD | -5.25% |
| 2024 Q1 | 561.9 Million USD | -14.42% |
| 2023 Q4 | 656.6 Million USD | 5.34% |
| 2023 Q1 | 462.6 Million USD | -14.54% |
| 2023 Q2 | 546.4 Million USD | 18.12% |
| 2023 Q3 | 623.3 Million USD | 14.07% |
| 2023 FY | 2.28 Billion USD | 21.55% |
| 2022 Q4 | 541.3 Million USD | 9.53% |
| 2022 FY | 1.88 Billion USD | 12.06% |
| 2022 Q1 | 398.1 Million USD | -15.76% |
| 2022 Q2 | 449.5 Million USD | 12.91% |
| 2022 Q3 | 494.2 Million USD | 9.94% |
| 2021 Q2 | 417.1 Million USD | 21.29% |
| 2021 Q3 | 446.9 Million USD | 7.14% |
| 2021 Q1 | 343.9 Million USD | -13.83% |
| 2021 FY | 1.68 Billion USD | 31.28% |
| 2021 Q4 | 472.6 Million USD | 5.75% |
| 2020 Q4 | 399.1 Million USD | 17.24% |
| 2020 Q1 | 256.5 Million USD | -17.07% |
| 2020 Q3 | 340.4 Million USD | 19.82% |
| 2020 FY | 1.28 Billion USD | 37.42% |
| 2020 Q2 | 284.1 Million USD | 10.76% |
| 2019 Q2 | 206.5 Million USD | 22.33% |
| 2019 FY | 931.5 Million USD | 40.31% |
| 2019 Q4 | 309.3 Million USD | 25.27% |
| 2019 Q1 | 168.8 Million USD | -24.24% |
| 2019 Q3 | 246.9 Million USD | 19.56% |
| 2018 FY | 663.9 Million USD | 34.91% |
| 2018 Q1 | 118.9 Million USD | -22.54% |
| 2018 Q2 | 153.6 Million USD | 29.18% |
| 2018 Q3 | 168.6 Million USD | 9.77% |
| 2018 Q4 | 222.8 Million USD | 32.15% |
| 2017 Q2 | 117.5 Million USD | 24.87% |
| 2017 Q3 | 127 Million USD | 8.09% |
| 2017 FY | 492.1 Million USD | 30.05% |
| 2017 Q4 | 153.5 Million USD | 20.87% |
| 2017 Q1 | 94.1 Million USD | -19.37% |
| 2016 Q3 | 101.1 Million USD | 18.25% |
| 2016 Q2 | 85.5 Million USD | 13.85% |
| 2016 Q4 | 116.7 Million USD | 15.43% |
| 2016 FY | 378.4 Million USD | 35.92% |
| 2016 Q1 | 75.1 Million USD | -17.65% |
| 2015 FY | 278.4 Million USD | 57.91% |
| 2015 Q4 | 91.2 Million USD | 22.09% |
| 2015 Q3 | 74.7 Million USD | 13.18% |
| 2015 Q2 | 66 Million USD | 41.94% |
| 2015 Q1 | 46.5 Million USD | -21.72% |
| 2014 Q3 | 47.2 Million USD | 18.3% |
| 2014 Q4 | 59.4 Million USD | 25.85% |
| 2014 FY | 176.3 Million USD | 76.12% |
| 2014 Q1 | 29.8 Million USD | -12.61% |
| 2014 Q2 | 39.9 Million USD | 33.89% |
| 2013 FY | 100.1 Million USD | 114.81% |
| 2013 Q4 | 34.1 Million USD | 23.55% |
| 2013 Q2 | 21.9 Million USD | 32.73% |
| 2013 Q1 | 16.5 Million USD | -6.08% |
| 2013 Q3 | 27.6 Million USD | 26.03% |
| 2012 Q3 | 8.4 Million USD | -25.27% |
| 2012 Q2 | 11.24 Million USD | 19.77% |
| 2012 Q1 | 9.38 Million USD | -12.21% |
| 2012 FY | 46.6 Million USD | 30.01% |
| 2012 Q4 | 17.56 Million USD | 109.09% |
| 2011 Q4 | 10.69 Million USD | 30.98% |
| 2011 Q3 | 8.16 Million USD | -31.23% |
| 2011 Q2 | 11.87 Million USD | 132.04% |
| 2011 Q1 | 5.11 Million USD | -26.8% |
| 2011 FY | 35.84 Million USD | 94.35% |
| 2010 Q2 | 4.51 Million USD | 30.64% |
| 2010 Q1 | 3.45 Million USD | -15.78% |
| 2010 Q4 | 6.98 Million USD | 101.06% |
| 2010 Q3 | 3.47 Million USD | -23.08% |
| 2010 FY | 18.44 Million USD | 403.77% |
| 2009 Q3 | 865 Thousand USD | 182.54% |
| 2009 FY | 3.66 Million USD | 166.21% |
| 2009 Q4 | 4.1 Million USD | 374.8% |
| 2009 Q2 | -1.04 Million USD | -298.48% |
| 2009 Q1 | -263 Thousand USD | 67.85% |
| 2008 Q4 | -818 Thousand USD | 57.4% |
| 2008 FY | -5.52 Million USD | 31.82% |
| 2008 Q2 | -1.41 Million USD | -2.25% |
| 2008 Q1 | -1.38 Million USD | 35.12% |
| 2008 Q3 | -1.92 Million USD | -36.07% |
| 2007 Q1 | -2.05 Million USD | 20.03% |
| 2007 Q2 | -2.04 Million USD | 0.34% |
| 2007 Q3 | -1.88 Million USD | 7.54% |
| 2007 Q4 | -2.12 Million USD | -12.6% |
| 2007 FY | -8.1 Million USD | 7.74% |
| 2006 Q4 | -2.56 Million USD | -0.63% |
| 2006 FY | -8.78 Million USD | 0.0% |
| 2006 Q3 | -2.54 Million USD | -58.1% |
| 2006 Q2 | -1.61 Million USD | 22.02% |
| 2006 Q1 | -2.06 Million USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -89660.784% |
| BrainsWay Ltd. | 23.09 Million USD | -9812.52% |
| Cerus Corporation | 86.4 Million USD | -2549.19% |
| Envoy Medical, Inc. | -473 Thousand USD | 484011.205% |
| electroCore, Inc. | 13.22 Million USD | -17206.064% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -3752195.082% |
| IceCure Medical Ltd | 1.3 Million USD | -175969.231% |
| Inogen, Inc. | 126.69 Million USD | -1706.565% |
| OrthoPediatrics Corp. | 111.25 Million USD | -1957.383% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 37933.058% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 4835531.807% |
| MaxCyte, Inc. | 36.54 Million USD | -6163.066% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -501283.3% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2690824.054% |
| Orthofix Medical Inc. | 486.27 Million USD | -370.703% |
| PAVmed Inc | -3.96 Million USD | 57783.972% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 41830.173% |
| RxSight, Inc. | 53.76 Million USD | -4157.231% |
| Sight Sciences, Inc. | 69.17 Million USD | -3208.854% |
| SI-BONE, Inc. | 109.42 Million USD | -1991.848% |
| TELA Bio, Inc. | 40.11 Million USD | -5606.272% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -1406.48% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -27573.8% |
| Acutus Medical, Inc. | -3.13 Million USD | 73064.616% |
| Talis Biomedical Corporation | 371 Thousand USD | -616854.178% |
| Spectral AI, Inc. | 7.88 Million USD | -28946.954% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 34822.391% |
| CVRx, Inc. | 33.03 Million USD | -6827.873% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -309409.064% |
| Bioventus Inc. | 328.19 Million USD | -597.425% |
| Venus Concept Inc. | 52.16 Million USD | -4287.64% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -14290.167% |
| LivaNova PLC | 771.25 Million USD | -196.778% |
| 908 Devices Inc. | 25.32 Million USD | -8939.175% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -637.872% |
| Nemaura Medical Inc. | -1.47 Million USD | 155133.352% |
| NeuroPace, Inc. | 48.12 Million USD | -4656.452% |
| LENSAR, Inc. | 21.1 Million USD | -10744.27% |
| Apyx Medical Corporation | 14.12 Million USD | -16108.044% |
| Cutera, Inc. | 41.49 Million USD | -5416.219% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -12298.571% |
| BioSig Technologies, Inc. | 18 Thousand USD | -12716011.111% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -2120.336% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -16712.84% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | -157.645% |
| Axonics, Inc. | 274.55 Million USD | -733.679% |
| Outset Medical, Inc. | 29 Million USD | -7792.759% |
| IRIDEX Corporation | 21.8 Million USD | -10396.171% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -3121.579% |
| IRadimed Corporation | 50.15 Million USD | -4463.355% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -797426.132% |
| INVO Bioscience, Inc. | 1.08 Million USD | -210637.494% |
| Telesis Bio, Inc. | 16.95 Million USD | -13403.835% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -1929.473% |
| Varex Imaging Corporation | 256.9 Million USD | -790.969% |
| Quipt Home Medical Corp. | 163.84 Million USD | -1296.991% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 563868.473% |
| Pulmonx Corporation | 50.75 Million USD | -4409.97% |
| Dynatronics Corporation | 7.63 Million USD | -29879.13% |
| Modular Medical, Inc. | -768 Thousand USD | 298133.854% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -41156.309% |
| Semler Scientific, Inc. | 61.2 Million USD | -3640.033% |
| InMode Ltd. | 411.34 Million USD | -456.45% |
| Bruker Corporation | 1.51 Billion USD | -50.903% |
| Cytosorbents Corporation | 22.39 Million USD | -10121.944% |
| Align Technology, Inc. | 2.71 Billion USD | 15.81% |
| Viveve Medical, Inc. | 620 Thousand USD | -369077.419% |
| ZimVie Inc. | 290.38 Million USD | -688.235% |
| Movano Inc. | -158 Thousand USD | 1448770.886% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -1991.733% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2690824.054% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -522.508% |
| Profound Medical Corp. | 4.51 Million USD | -50606.454% |
| Insulet Corporation | 1.15 Billion USD | -97.336% |
| enVVeno Medical Corporation | -546 Thousand USD | 419312.454% |
| Surmodics, Inc. | 93.05 Million USD | -2359.807% |
| iCAD, Inc. | 14.53 Million USD | -15646.423% |
| Nuwellis, Inc. | 4.98 Million USD | -45834.176% |
| Biotricity, Inc. | 8.35 Million USD | -27291.372% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -589.831% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 637575.387% |
| InspireMD, Inc. | 1.8 Million USD | -126568.511% |
| PAVmed Inc. | -3.96 Million USD | 57783.972% |
| BIOLASE, Inc. | 16.72 Million USD | -13586.318% |
| Beyond Air, Inc. | -1.3 Million USD | 175226.243% |
| FONAR Corporation | 45.14 Million USD | -4970.664% |
| AxoGen, Inc. | 127.87 Million USD | -1689.965% |
| Vivani Medical, Inc. | -357 Thousand USD | 641248.459% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -1072.995% |
| Inari Medical, Inc. | 434.56 Million USD | -426.712% |
| UFP Technologies, Inc. | 112.22 Million USD | -1939.563% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -18283309.218% |
| Tenon Medical, Inc. | 1.24 Million USD | -184339.968% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 2825902.469% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -87026.854% |
| AdaptHealth Corp. | 479.56 Million USD | -377.288% |
| Sintx Technologies, Inc. | 1.84 Million USD | -124094.249% |
| NanoVibronix, Inc. | 1.53 Million USD | -148819.974% |
| Quanterix Corporation | 70.64 Million USD | -3139.957% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 563868.473% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -16179.516% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -4236.681% |
| TransMedics Group, Inc. | 154.09 Million USD | -1385.402% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -51301.302% |
| NeuroMetrix, Inc. | 3.94 Million USD | -57884.812% |
| Hyperfine, Inc. | 4.75 Million USD | -48016.46% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -2039.619% |
| Biomerica, Inc. | 611 Thousand USD | -374515.385% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -5390.63% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 293189.871% |
| Silk Road Medical, Inc | 127.08 Million USD | -1701.064% |